Omicron-Specific Vaccine Expected In Six Months: Serum Institute's Adar Poonawalla To NDTV
The Serum Institute of India in collaboration with Novavax is working on a vaccine specific to BA.5, a sub-variant of Omicron
Stay updated with breaking news from Covid Task Force Chief. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Serum Institute of India in collaboration with Novavax is working on a vaccine specific to BA.5, a sub-variant of Omicron
The massive surge in the number of covid cases over the last one week is indicative of a third wave of the pandemic, says Dr N K Arora, the chairman of the COVID-19 working group of the NTAGI
It is absolutely safe, underlined the head of the India's vaccine task force chief on the vexing question of extending the shelf life of Covid vaccine, Covaxin, being given to teenagers (15-18) under the national Covid immunisation programme.
Amid concerns over the Omicron variant of coronavirus, Covid Task Force chief Dr VK Paul on Tuesday said India should have vaccine platforms that are "adaptable quickly" with changing nature of the variants.